Vaccines
28 September 2020
INOVIO reports FDA partial clinical hold for planned Phase 2 / 3 trial of COVID-19 vaccine candidate INO-480025 September 2020
Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer25 September 2020
Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis25 September 2020
Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate23 September 2020
Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children23 September 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate23 September 2020
St. Louis-based Precision Virologics and India’s Biotech leader Bharat Biotech obtain rights to intranasal COVID-19 vaccine technology21 September 2020
OSE Immunotherapeutics Presents Positive Step-1 Phase 3 Results for Tedopi® in NSCLC at the European Society for Medical Oncology Virtual Congress 202018 September 2020
Ufovax Announces Its Self-Assembling NanoParticles as the Next-Generation Vaccine Solution for COVID-1916 September 2020
Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-10114 September 2020
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program12 September 2020
COVID-19 vaccine AZD1222 clinical trials resumed in the UK10 September 2020
Axon Announces Positive Pre-Clinical Results for its Peptide Vaccine (ACvac1) Against Novel Coronavirus10 September 2020
Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-1910 September 2020
Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers10 September 2020
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause9 September 2020
Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate9 September 2020
Biopharma Leaders Unite to Stand with Science8 September 2020
AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.8 September 2020
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies8 September 2020
Vaxil Announces Positive Results on CorVax™ in vivo StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports